Zhangzhou Pientzehuang Pharmaceutical., Ltd

Equities

600436

CNE000001F21

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
225.7 CNY +2.48% Intraday chart for Zhangzhou Pientzehuang Pharmaceutical., Ltd -0.15% -6.74%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. Signs Cooperation Agreement with Beijing Tong Ren Tang Group CI
Pientzehuang Pharmaceutical's Profit Climbs 12.6% in 2023 MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhangzhou Pientzehuang to Raise Price of Multifunctional TCM by 29% MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pientzehuang Logs Slowest Profit Growth in 12 Years MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pien Tze Huang Pharma’s Q3 Profit Falls 18% as Revenue Slips 3% MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
FTSE Russell makes additions including PetroChina in review of China indices RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Market Chatter: Century-Old Chinese Companies Tap Into Stock Market to Fuel Growth MT
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Exclusive: Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TCM - sources RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
China stocks end lower as high-flying consumer shares retreat RE
Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020 CI
Zhangzhou Pientzehuang Pharmaceutical., Ltd Approves Proposal of Investing in Newly Establishing Science and Technology Building CI
Chart Zhangzhou Pientzehuang Pharmaceutical., Ltd
More charts
Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. is specialized in developing and marketing traditional Chinese medicine products. The company offers medicines and health products, cosmetic products, dietary compounds, etc.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
225.7 CNY
Average target price
285.6 CNY
Spread / Average Target
+26.56%
Consensus
  1. Stock Market
  2. Equities
  3. 600436 Stock
  4. News Zhangzhou Pientzehuang Pharmaceutical., Ltd
  5. Pien Tze Huang Pharma’s Q3 Profit Falls 18% as Revenue Slips 3%